Morphosys Ag (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
MOR Nasdaq 8731 https://www.morphosys.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Morphosys Ag (ADR)

MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting - Apr 24th, 2024 3:00 pm
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate - Apr 12th, 2024 5:55 pm
Novartis (NVS) to Undertake Job Cuts in Development Department - Apr 11th, 2024 1:45 pm
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis - Apr 11th, 2024 1:00 pm
UPDATE 3-Novartis begins tender offer for cancer-focused MorphoSys - Apr 11th, 2024 8:39 am
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act - Mar 22nd, 2024 6:50 am
MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript - Mar 15th, 2024 2:37 pm
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - Mar 13th, 2024 8:02 pm
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys - Mar 11th, 2024 2:36 pm
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024 - Mar 8th, 2024 12:31 pm
Invitation to MorphoSys' Full Year Results 2023 Conference Call on March 14, 2024 - Mar 7th, 2024 8:15 pm
MorphoSys AG Unsponsored ADR (MOR) is a Great Momentum Stock: Should You Buy? - Mar 4th, 2024 5:00 pm
What Makes MorphoSys AG Unsponsored ADR (MOR) a Strong Momentum Stock: Buy Now? - Feb 15th, 2024 5:00 pm
Q4 2023 Incyte Corp Earnings Call - Feb 14th, 2024 6:15 am
Biotech Stock Roundup: GILD, AMGN & BMY's Q4 Results, MOR Up on NVS Deal & More - Feb 8th, 2024 3:56 pm
Novartis (NVS) to Buy MorphoSys & Add Late-Stage Oncology Drug - Feb 6th, 2024 4:16 pm
MorphoSys to sell to Novartis for $2.9B, offload cancer drug to Incyte - Feb 6th, 2024 9:30 am
Biotech Stock MorphoSys Catapults 56% As Novartis Agrees To Buy It For $2.9 Billion - Feb 5th, 2024 11:54 pm
UPDATE 3-Novartis to acquire cancer-focused MorphoSys for $2.9 bln - Feb 5th, 2024 11:35 pm